Loading…

MicroPort Scientific Corporation announced that its subsidiary MicroPort CardioFlow will acquire CRM Cayman through a subsidiary-to-subsidiary merger, valuing CRM Cayman at $680 million. The integration is expected to complete in Q1 2026.
“Under the terms, MicroPort CardioFlow will acquire CRM Cayman through a subsidiary‑to‑subsidiary merger, valuing the Cayman‑based entity at USD 680 million in pre‑transaction equity.”flcube.com
Summarized from public sources; check the original articles before acting on it.